Literature DB >> 15364928

Rafts can trigger contact-mediated secretion of bacterial effectors via a lipid-based mechanism.

Françoise G van der Goot1, Guy Tran van Nhieu, Abdelmounaaïm Allaoui, Phillipe Sansonetti, Frank Lafont.   

Abstract

Infection by the Gram-negative bacterial pathogen Shigella flexneri depends on its ability to invade host cells. Bacterial engulfment requires a functional type III secretion system (TTSS) allowing the translocation into host cells of bacterial effectors that activate cell-signaling cascades. We demonstrated previously that specialized lipid membrane domains enriched in cholesterol and sphingolipids (rafts) are involved during early steps of invasion, namely in binding and host cell entry. In this study, we addressed the issue of contact-mediated secretion by the TTSS. We show that contact-mediated and TTSS-induced hemolysis depend on the presence of cholesterol on the host cell surface. We found that purified detergent resistant membranes were able to activate TTSS. Finally, we found that artificial liposomes, devoid of proteins, were able to activate the TTSS but only when their composition mimicked that of lipid rafts. Altogether, these data indicate that specific lipid packing can trigger contact-mediated secretion by S. flexneri.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364928     DOI: 10.1074/jbc.M406824200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria.

Authors:  Daniela Büttner
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

Review 2.  Hijacking the endocytic machinery by microbial pathogens.

Authors:  Ann En-Ju Lin; Julian Andrew Guttman
Journal:  Protoplasma       Date:  2010-06-25       Impact factor: 3.356

3.  Physical association of Arabidopsis hypersensitive induced reaction proteins (HIRs) with the immune receptor RPS2.

Authors:  Yiping Qi; Kenichi Tsuda; Le V Nguyen; Xia Wang; Jinshan Lin; Angus S Murphy; Jane Glazebrook; Hans Thordal-Christensen; Fumiaki Katagiri
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

4.  Bordetella adenylate cyclase toxin promotes calcium entry into both CD11b+ and CD11b- cells through cAMP-dependent L-type-like calcium channels.

Authors:  César Martín; Geraxane Gómez-Bilbao; Helena Ostolaza
Journal:  J Biol Chem       Date:  2009-10-29       Impact factor: 5.157

5.  The Coxiella Burnetii type IVB secretion system (T4BSS) component DotA is released/secreted during infection of host cells and during in vitro growth in a T4BSS-dependent manner.

Authors:  Brandon E Luedtke; Saugata Mahapatra; Erika I Lutter; Edward I Shaw
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

6.  Identification and characterization of small-molecule inhibitors of Yop translocation in Yersinia pseudotuberculosis.

Authors:  Dana E Harmon; Alison J Davis; Cynthia Castillo; Joan Mecsas
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191

Review 7.  Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.

Authors:  Gunnar N Schroeder; Hubert Hilbi
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

8.  Induction of type III secretion by cell-free Chlamydia trachomatis elementary bodies.

Authors:  Wendy P Jamison; Ted Hackstadt
Journal:  Microb Pathog       Date:  2008-10-17       Impact factor: 3.738

Review 9.  Hijacking and Use of Host Lipids by Intracellular Pathogens.

Authors:  Alvaro Toledo; Jorge L Benach
Journal:  Microbiol Spectr       Date:  2015-12

10.  Liposomes recruit IpaC to the Shigella flexneri type III secretion apparatus needle as a final step in secretion induction.

Authors:  Chelsea R Epler; Nicholas E Dickenson; Andrew J Olive; Wendy L Picking; William D Picking
Journal:  Infect Immun       Date:  2009-05-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.